Journal article
Insights into the endoscopic management of esophageal achalasia
Therapeutic advances in gastrointestinal endoscopy, Vol.14, pp.26317745211014706-26317745211014706
05/05/2021
DOI: 10.1177/26317745211014706
PMCID: PMC8114742
PMID: 34017943
Abstract
Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities are aimed at disruption of the esophagogastric junction and vary widely from pharmacological to endoscopic to surgical. Traditional endoscopic therapy includes pneumatic dilation, botulinum toxin injection, and peroral endoscopic myotomy. This review aims to provide an overview of the endoscopic management of achalasia, while focusing on the utilization of peroral endoscopic myotomy and other novel approaches.
Details
- Title: Subtitle
- Insights into the endoscopic management of esophageal achalasia
- Creators
- Elizabeth Brindise - University of IowaMouen A. Khashab - Johns Hopkins HospitalRami El Abiad - University of Iowa Hospitals and Clinics
- Resource Type
- Journal article
- Publication Details
- Therapeutic advances in gastrointestinal endoscopy, Vol.14, pp.26317745211014706-26317745211014706
- DOI
- 10.1177/26317745211014706
- PMID
- 34017943
- PMCID
- PMC8114742
- NLM abbreviation
- Ther Adv Gastrointest Endosc
- ISSN
- 2631-7745
- eISSN
- 2631-7745
- Publisher
- SAGE Publications
- Language
- English
- Date published
- 05/05/2021
- Academic Unit
- Gastroenterology and Hepatology; Internal Medicine
- Record Identifier
- 9984359948202771
Metrics
8 Record Views